MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Mabxience.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Mabxience.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Mabxience.com most likely does not offer any adult content.
Popular pages
-
Leading international biopharmaceutical company
BIOPHARMACEUTICAL DEVELOPMENT Experts in biologics, specialized in biosimilars We are a leading vertically integrated biopharmaceuticals company, committed to improving patient access to treatme...
-
Fresenius Kabi completes majority stake acquisition of mAbxience Holding S.L., significantly
A further milestone for Fresenius Kabi’s Vision 2026 growth strategy as the company invests on the core growth vector “Broaden in Biopharma” The combination of both companies positions Fresenius Ka...
-
About us - mAbxience
ABOUT US Global experts in biopharmaceutical development and manufacture THE COMPANY We’re a vertically integrated biotechnology company With over a decade of experience, mAbxience is a
-
mAbxience and Abbott Sign Strategic Agreement to Broaden Access to a Pipeline of Biosimilars in Key
Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia and Middle East and Africa mAbxience Holdings S.L (a Fresenius Kabi majority-owned ...
-
mAbxience Announces Licensing Agreement with Intas Pharmaceuticals Ltd. for Etanercept Biosimilar
Discover the groundbreaking collaboration between mAbxience and Intas Pharmaceuticals Ltd. as they announce a licensing agreement for an Etanercept biosimilar, targeting autoimmune diseases in over 15...
-
Publication of the final data from the clinical trial for mAbxience bevacizumab in metastatic
The prestigious scientific journal The Lancet Gastroenterology and Hepatology journal has published the results of the comparative study of pharmacokinetics, efficacy, safety and immunogenicity of bev...